These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37708123)

  • 1. Prevalence and knowledge about acute mountain sickness in the Western Alps.
    Berger MM; Hüsing A; Niessen N; Schiefer LM; Schneider M; Bärtsch P; Jöckel KH
    PLoS One; 2023; 18(9):e0291060. PubMed ID: 37708123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps.
    Mairer K; Wille M; Burtscher M
    High Alt Med Biol; 2010; 11(4):343-8. PubMed ID: 21190503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of acute mountain sickness in the Eastern Alps.
    Mairer K; Wille M; Bucher T; Burtscher M
    High Alt Med Biol; 2009; 10(3):239-45. PubMed ID: 19775213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review.
    Meier D; Collet TH; Locatelli I; Cornuz J; Kayser B; Simel DL; Sartori C
    JAMA; 2017 Nov; 318(18):1810-1819. PubMed ID: 29136449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of acute mountain sickness by different score protocols in the Swiss Alps.
    Maggiorini M; Müller A; Hofstetter D; Bärtsch P; Oelz O
    Aviat Space Environ Med; 1998 Dec; 69(12):1186-92. PubMed ID: 9856545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and severity of acute mountain sickness and associated symptoms in children trekking on Xue Mountain, Taiwan.
    Cheng FY; Jeng MJ; Lin YC; Wang SH; Wu SH; Li WC; Huang KF; Chiu TF
    PLoS One; 2017; 12(8):e0183207. PubMed ID: 28832689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
    J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas.
    Basnyat B; Subedi D; Sleggs J; Lemaster J; Bhasyal G; Aryal B; Subedi N
    Wilderness Environ Med; 2000; 11(2):89-93. PubMed ID: 10921358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Sleeping Altitude on Symptoms of Acute Mountain Sickness on Mt. Fuji.
    Horiuchi M; Uno T; Endo J; Handa Y; Hasegawa T
    High Alt Med Biol; 2018 Jun; 19(2):193-200. PubMed ID: 29741971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High altitude illness in pilgrims after rapid ascent to 4380 M.
    Zafren K; Pun M; Regmi N; Bashyal G; Acharya B; Gautam S; Jamarkattel S; Lamichhane SR; Acharya S; Basnyat B
    Travel Med Infect Dis; 2017; 16():31-34. PubMed ID: 28285976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m).
    Pesce C; Leal C; Pinto H; González G; Maggiorini M; Schneider M; Bärtsch P
    High Alt Med Biol; 2005; 6(2):158-66. PubMed ID: 16060850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
    Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
    Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
    Phillips L; Basnyat B; Chang Y; Swenson ER; Harris NS
    High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 m.
    Berger MM; Macholz F; Lehmann L; Dankl D; Hochreiter M; Bacher B; Bärtsch P; Mairbäurl H
    J Appl Physiol (1985); 2017 Nov; 123(5):1228-1234. PubMed ID: 28798201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Determinants of Acute Mountain Sickness and Summit Success on a 6-Day Ascent of Mount Kilimanjaro (5895 m).
    Lawrence JS; Reid SA
    Wilderness Environ Med; 2016 Mar; 27(1):78-84. PubMed ID: 26948557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are Pre-Ascent Low-Altitude Saliva Cortisol Levels Related to the Subsequent Acute Mountain Sickness Score? Observations from a Field Study.
    Gatterer H; Bernatzky G; Burtscher J; Rainer M; Kayser B; Burtscher M
    High Alt Med Biol; 2019 Dec; 20(4):337-343. PubMed ID: 31411495
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of acute mountain sickness at 3500 m within and between families: a prospective cohort study.
    Kriemler S; Bürgi F; Wick C; Wick B; Keller M; Wiget U; Schindler C; Kaufmann BA; Kohler M; Bloch K; Brunner-La Rocca HP
    High Alt Med Biol; 2014 Apr; 15(1):28-38. PubMed ID: 24559431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between physiological responses after exercise at low altitude and acute mountain sickness upon ascent is sex-dependent.
    Shen Y; Yang YQ; Liu C; Yang J; Zhang JH; Jin J; Tan H; Yuan FZ; Ke JB; He CY; Zhang LP; Zhang C; Yu J; Huang L
    Mil Med Res; 2020 Nov; 7(1):53. PubMed ID: 33148321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro.
    Jackson SJ; Varley J; Sellers C; Josephs K; Codrington L; Duke G; Njelekela MA; Drummond G; Sutherland AI; Thompson AA; Baillie JK
    High Alt Med Biol; 2010; 11(3):217-22. PubMed ID: 20919888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does change in barometric pressure per given time at high altitude influence symptoms of acute mountain sickness on Mount Fuji? A pilot study.
    Horiuchi M; Watanabe M; Mitsui S; Uno T
    J Physiol Anthropol; 2021 May; 40(1):6. PubMed ID: 33962688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.